UP

The possible price tag for US COVID-19 vaccine

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

Earlier this week, chief executive of the US biotechnology company Moderna Stephane Bancel announced that they had kicked off the third phase of human trials of a vaccine against the coronavirus.

Axar.az reports citing foreign media that the Financial Times (FT) has quoted unnamed sources as saying that the US biotechnology company Moderna plans to price its COVID-19 vaccine at about $50-$60 per course.

The sources claimed that the proposed price for the mRNA-1273 vaccine would apply to the US and “other high-income countries”.
The two-dose course costs are at least $11 more than that of the US pharmaceutical giant Pfizer and its German counterpart BioNTech, which earlier clinched a deal with the US government on a $39 vaccine.

Date
2020.07.29 / 17:28
Author
Axar.az
Comments
See also

WHO: Gaza's hospital not functional after Israel raids

This country is starting mass vaccination against fever

Urgent call from WHO on measles

The creator of the Sputnik V vaccine has died

Thousands of people died from coronavirus on the holiday

Uzbekistan develops edible COVID vaccine made from tomato

Infection has increased, use the mask! - Warning

Diseases could kill more than bombings in Gaza - WHO

A vaccine against cancer will be developed

World first: Human eye transplanted

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla